Relay Therapeutics, Inc. (RLAY) shares ended the last trading session 16.4% higher at $12.54. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Relay Therapeutics announced that initial clinical and preclinical data for its PI3K⍺-targeting candidate zovegalisib in vascular anomalies will be presented at the International Society for the Study ...

Relay Therapeutics (RLAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more ...

The average one-year price target for Relay Therapeutics (NasdaqGM:RLAY) has been revised to $17.43 / share. This is an increase of 17.50% from the prior estimate of $14.84 dated February 21, 2026.